Search - tctmd.com

Displaying 841 - 860 of 1032

Sort: Relevancy | Date

Presentation TCT 2014

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Ron Waksman

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Stephane Cook

September 16, 2014

Presentation TCT 2014

Use Of Optical Coherence Tomography To Study The Role Of Non-Compliant Balloon Post-Dilation In Optimization Of Bioresorbable Vascular Scaffolds

Presenter: Jaya Chandrasekhar

September 16, 2014

Presentation TCT 2014

Short- and long-term safety evaluation of a novel bioresorbable scaffold in a miniature swine coronary artery model

Presenter: Kazuyuki Yahagi

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Arif Al Nooryani

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Yoshinobu Onuma

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Jens Flensted Lassen

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcation Requires Different Technique

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, John A. Ormiston

September 15, 2014

Presentation TCT 2014

IVUS to Guide Bioresorbable Scaffold Implantation

Presenter: Patrick A. Calvert, Gary S. Mintz, Bernhard Witzenbichler, Azeem Latib

September 15, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

Presentation TCT 2014

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

Presenter: Pieter C. Smits

September 14, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Advertisement

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Use Of Optical Coherence Tomography To Study The Role Of Non-Compliant Balloon Post-Dilation In Optimization Of Bioresorbable Vascular Scaffolds

Short- and long-term safety evaluation of a novel bioresorbable scaffold in a miniature swine coronary artery model

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Bioresorbable Scaffold Use in Bifurcation Requires Different Technique

IVUS to Guide Bioresorbable Scaffold Implantation

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content